Major Depressive Disorder, Recurrent
This patient meets diagnostic criteria for Major Depressive Disorder (MDD), recurrent episode, based on the presence of at least five depressive symptoms lasting two months with this being the third episode in four years 1.
Diagnostic Criteria Met
The patient clearly satisfies MDD diagnostic requirements as defined by standard psychiatric criteria 1:
Core symptoms present:
- Depressed mood (crying episodes, social withdrawal)
- Low energy/fatigue
- Feelings of worthlessness
- Poor concentration
- Sleep disturbance
Duration: Two months (exceeds the required 2-week minimum)
Functional impairment: Social withdrawal indicates disruption in normal functioning
Pattern: Third episode in four years establishes this as recurrent MDD rather than a single episode
Key Diagnostic Considerations
The "recurrent" specifier is critical here. With three distinct depressive episodes over four years, this patient has demonstrated a pattern of recurrence that significantly impacts treatment planning and prognosis. Each new episode after recovery from a previous one constitutes recurrent MDD rather than a chronic single episode 1.
This appears to be uncomplicated MDD given the absence of:
- Suicidal ideation
- Psychotic features
- Psychomotor retardation
- Extreme functional impairment
Research suggests uncomplicated MDD has a more benign prognosis than complicated presentations 2, though the recurrent nature warrants aggressive treatment to prevent future episodes.
Clinical Significance of Specific Symptoms
The presence of feelings of worthlessness is particularly noteworthy, as this symptom has been identified as a central feature in depression networks and is associated with higher risk for symptom persistence and potential progression to suicidal ideation in future episodes 3, 4, 5. While the patient currently denies suicidal ideation, worthlessness is a symptom that warrants close monitoring.
Treatment Implications
Given the recurrent nature with three episodes in four years, this patient requires both acute treatment and maintenance therapy to prevent future recurrences 1. The guideline recommendation is to select between cognitive behavioral therapy or second-generation antidepressants after discussing treatment effects, adverse effects, cost, accessibility, and patient preferences 1.
For a 28-year-old with recurrent MDD, either CBT or second-generation antidepressants are appropriate first-line options, with combination therapy potentially warranted given the recurrent pattern 1.